WO2007051201A3 - Muteines des sites de glycosylation de tlr3 et leurs procedes d'utilisation - Google Patents

Muteines des sites de glycosylation de tlr3 et leurs procedes d'utilisation Download PDF

Info

Publication number
WO2007051201A3
WO2007051201A3 PCT/US2006/060357 US2006060357W WO2007051201A3 WO 2007051201 A3 WO2007051201 A3 WO 2007051201A3 US 2006060357 W US2006060357 W US 2006060357W WO 2007051201 A3 WO2007051201 A3 WO 2007051201A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
glycosylation site
muteins
tlr3
site muteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/060357
Other languages
English (en)
Other versions
WO2007051201A2 (fr
Inventor
Karen E Duffy
Mark Cunningham
M Lamine Mbow
Robert T Sarisky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Priority to DK06846186.2T priority Critical patent/DK1945657T3/da
Priority to EP06846186A priority patent/EP1945657B1/fr
Priority to PL06846186T priority patent/PL1945657T3/pl
Priority to AT06846186T priority patent/ATE530562T1/de
Priority to ES06846186T priority patent/ES2375999T3/es
Priority to JP2008538208A priority patent/JP2009515511A/ja
Publication of WO2007051201A2 publication Critical patent/WO2007051201A2/fr
Publication of WO2007051201A3 publication Critical patent/WO2007051201A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention se rapporte à des mutéines des sites de glycosylation de TLR3, à des acides nucléiques codant lesdites mutéines, et à des procédés permettant de moduler l'activité de TLR3 dans une cellule.
PCT/US2006/060357 2005-10-28 2006-10-30 Muteines des sites de glycosylation de tlr3 et leurs procedes d'utilisation Ceased WO2007051201A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DK06846186.2T DK1945657T3 (da) 2005-10-28 2006-10-30 TLR3-glycosyleringsstedsmuteiner samt fremgangsmåde til deres anvendelse
EP06846186A EP1945657B1 (fr) 2005-10-28 2006-10-30 Mutéines des sites de glycosylation de Tlr3 et leurs procédés d'utilisation
PL06846186T PL1945657T3 (pl) 2005-10-28 2006-10-30 Muteiny Tlr3 zmienione w miejscu glikozylacji i ich zastosowanie
AT06846186T ATE530562T1 (de) 2005-10-28 2006-10-30 Tlr3-glycosylierungsstandortmuteine und verwendungsverfahren dafür
ES06846186T ES2375999T3 (es) 2005-10-28 2006-10-30 Mute�?nas de sitio de glucosilación tlr3 y procedimientos de uso.
JP2008538208A JP2009515511A (ja) 2005-10-28 2006-10-30 Ｔｌｒ３のグリコシル化部位ムテインおよび使用方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73110505P 2005-10-28 2005-10-28
US60/731,105 2005-10-28

Publications (2)

Publication Number Publication Date
WO2007051201A2 WO2007051201A2 (fr) 2007-05-03
WO2007051201A3 true WO2007051201A3 (fr) 2008-02-14

Family

ID=37968693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/060357 Ceased WO2007051201A2 (fr) 2005-10-28 2006-10-30 Muteines des sites de glycosylation de tlr3 et leurs procedes d'utilisation

Country Status (11)

Country Link
US (1) US20070203064A1 (fr)
EP (1) EP1945657B1 (fr)
JP (1) JP2009515511A (fr)
AT (1) ATE530562T1 (fr)
CY (1) CY1112512T1 (fr)
DK (1) DK1945657T3 (fr)
ES (1) ES2375999T3 (fr)
PL (1) PL1945657T3 (fr)
PT (1) PT1945657E (fr)
SI (1) SI1945657T1 (fr)
WO (1) WO2007051201A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010040054A2 (fr) * 2008-10-02 2010-04-08 Centocor Ortho Biotech Inc. Procédés de suppression de l'activité des récepteurs de type toll
EP2483406A2 (fr) 2009-09-30 2012-08-08 President and Fellows of Harvard College Procédés de modulation de l'autophagie par la modulation de produits géniques inhibant l'autophagie
US20220170042A1 (en) * 2020-11-27 2022-06-02 Wyvern Pharmaceuticals Inc. Compositions and methods for regulating production of a precursor protein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5243540A (en) * 1991-04-03 1993-09-07 The United States Of America As Represented By The Secretary Of The Army Computer-driven amino acid indexer for peptide synthesis
US6900016B1 (en) * 2000-09-08 2005-05-31 Applera Corporation Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5243540A (en) * 1991-04-03 1993-09-07 The United States Of America As Represented By The Secretary Of The Army Computer-driven amino acid indexer for peptide synthesis
US6900016B1 (en) * 2000-09-08 2005-05-31 Applera Corporation Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof

Also Published As

Publication number Publication date
JP2009515511A (ja) 2009-04-16
EP1945657A4 (fr) 2009-06-03
ATE530562T1 (de) 2011-11-15
ES2375999T3 (es) 2012-03-08
DK1945657T3 (da) 2012-02-06
US20070203064A1 (en) 2007-08-30
CY1112512T1 (el) 2015-12-09
EP1945657A2 (fr) 2008-07-23
WO2007051201A2 (fr) 2007-05-03
EP1945657B1 (fr) 2011-10-26
PL1945657T3 (pl) 2012-03-30
PT1945657E (pt) 2012-02-02
SI1945657T1 (sl) 2012-03-30

Similar Documents

Publication Publication Date Title
WO2005103076A3 (fr) Variants d'erythropoietine
IL179942A0 (en) Electrochemical methods, devices, and structures
CA121249S (en) Electrode array
EP1912667A4 (fr) Lyophilisats proteiques concentres, procedes associes et leurs utilisations
WO2009051717A3 (fr) Variantes du facteur ix humain qui présentent une demi-vie prolongée
WO2006074440A3 (fr) Systeme de cloture
WO2007073484A3 (fr) Procedes et systemes de conduite d’operations de recherche
CA107739S (en) Toy building element
ZA200500171B (en) Xylanases, nucleic acids encoding them and methods for making and using them
WO2006068972A3 (fr) Dispositifs d'ingenierie tissulaire destines a reparer et a regenerer des tissus
WO2003083054A9 (fr) Amylases, acides nucleiques les codant et procedes de fabrication et d'utilisation correspondants
PL1748954T3 (pl) Fosfolipazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania
EP1754234A4 (fr) Piles a combustible a faible teneur en platine et procede de fabrication desdites piles
NO20053357D0 (no) Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.
GB0321228D0 (en) Modulating cell activity
WO2005108428A3 (fr) Variants d'epissage de cd40 et leurs utilisations
ZA200706646B (en) Brown algae cell lyophilisate, method for the obtention thereof
PL1819214T3 (pl) Szklarnia, układ sterowania klimatem szklarni oraz sposób sterowania klimatem szklarni
WO2007051201A3 (fr) Muteines des sites de glycosylation de tlr3 et leurs procedes d'utilisation
WO2006029389A9 (fr) Enzymes de transformation de tryptophanes, acides nucleiques codant pour de telles enzymes et leurs procedes de fabrication et d'utilisation
WO2005092924A3 (fr) Rab9a, rab11a et leurs modulateurs lies a une maladie infectieuse
EP1961771A4 (fr) Hyaluronate de bismuth, procédé de préparation et utilisation de celui-ci
IL172416A0 (en) Modified human acid sphingomyelinase having increased activity, and methods for making the same
CA109415S (en) Printer
AU2003214116A1 (en) Z-substituted acrylamides, methods for production thereof and agents comprising the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2008538208

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006846186

Country of ref document: EP